Predicting Potential of Rapid Tumor Growth in Small to Medium Vestibular Schwannomas on the Basis of Sway Assessed Using Posturography.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
04 2021
Historique:
received: 08 10 2020
revised: 30 12 2020
accepted: 31 12 2020
pubmed: 15 1 2021
medline: 28 7 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

The relationship between quantitative posturography results and growth of vestibular schwannomas (VSs) during conservative management has not been studied. We aimed to clarify the relationship between the presence of disequilibrium based on posturographic measurement and VS growth. This retrospective, single-center study included 53 patients with VSs (Koos stage I or II) managed conservatively after initial diagnosis. Radiographic progression was considered present if 20% volumetric growth was observed over the imaging interval. Posturography was performed at initial diagnosis, and sway velocity (SV) and sway area were calculated. Tumor growth-free survival was estimated using the Kaplan-Meier method. Mean follow-up period was 2.87 ± 2.58 years, up to tumor growth detection or last follow-up magnetic resonance imaging. Tumor growth incidence was 40.8% and 61.2% at 2 and 5 years, respectively. Cerebellopontine angle extension and SV with eyes open were related to tumor growth. Tumor growth-free survival of patients with cerebellopontine angle extension and patients with intracanalicular tumor at 2 years was 37.3% and 76.4%, respectively. Tumor growth-free survival of patients with SV >2.06 cm/second and patients with SV ≤2.06 cm/second at 2 years was 30.8% and 68.9%, respectively. The Cox hazard model demonstrated a significant risk for future tumor growth with SV >2.06 cm/second (relative risk, 2.475; 95% confidence interval, 1.11-5.37, P = 0.027). We demonstrated a positive correlation between SV with eyes open and future tumor growth. Posturographic data are objective and quantitative; thus, SV may be a potential predictor of future growth of VSs.

Identifiants

pubmed: 33444828
pii: S1878-8750(21)00019-X
doi: 10.1016/j.wneu.2020.12.175
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e406-e414

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Yoshinori Higuchi (Y)

Departments of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: yhiguchi@faculty.chiba-u.jp.

Shiro Ikegami (S)

Departments of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Kentaro Horiguchi (K)

Departments of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Kyoko Aoyagi (K)

Departments of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan; Department of Neurosurgery, Chiba Cerebral and Cardiovascular Center, Chiba, Japan.

Osamu Nagano (O)

Department of Neurosurgery, Chiba Cerebral and Cardiovascular Center, Chiba, Japan.

Toru Serizawa (T)

Tokyo Gamma Unit Center, Tsukiji Neurological Clinic, Tokyo, Japan.

Yosuke Tajima (Y)

Department of Neurosurgery, Matsudo City General Hospital, Chiba, Japan.

Toyoyuki Hanazawa (T)

Departments of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Iwao Yamakami (I)

Department of Neurosurgery, Seikei-kai Chiba Medical Center, Chiba, Japan.

Yasuo Iwadate (Y)

Departments of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH